Bausch Health Companies Inc carries out the development, manufacture, and marketing of medicines for eye health, gastroenterology (GI), and dermatology, as well as a range of branded pharmaceuticals, generic and branded generic pharmaceuticals, and over-the-counter (OTC) products and medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetic devices. The company operates its business through five segments – Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The company’s Bausch + Lomb segment consists of Bausch + Lomb vision care, consumer, surgical, and ophthalmic pharmaceuticals. Its Salix segment covers the sale of GI products. The International Rx segment covers branded pharmaceutical products, branded generic pharmaceutical, and OTC products. Its Ortho Dermatologics segment includes ortho dermatologics (dermatological) products. The Diversified Products segment consists of pharmaceutical products in the areas of neurology and other conditions, generic products, and dentistry products.